Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
Eptifibatide: The evidence for its role in the management of acute coronary syndromes
Core Evidence, 08/05/09
Shah I et al. – Several large, randomized controlled trials show that eptifibatide as adjunctive therapy to standard care in patients with non–ST segment elevation acute coronary syndrome is associated with a significant reduction in the incidence of death or myocardial infarction. Data are limited regarding the use of eptifibatide in patients with ST segment elevation myocardial infarction. Cost–effectiveness analysis indicates that eptifibatide is associated with a favorable cost–effectiveness ratio relative to standard care. According to US cost–effectiveness analysis about 70% of the acquisition costs of eptifibatide are offset by the reduced medical resource consumption during the first year. Eptifibatide was well tolerated in most of the trials. Bleeding is the most commonly reported adverse event, with most major bleeding episodes occurring at the vascular access site. Major intracranial bleeds, stroke, or profound thrombocytopenia rarely occurred during eptifibatide treatment.
Related Articles
Acute Coronary Syndromes: Diagnosis and Management, Part II
Mayo Clinic Proceedings, 11/03/09
Relevance Score: 83%
Activated factor XII type A and B-type natriuretic peptide are complementary and incremental predictors of mortality in patients following admission with acute coronary syndrome
Blood Coagulation & Fibrinolysis, 11/03/09
Relevance Score: 83%
Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study
Atherosclerosis, 10/13/09
Relevance Score: 83%
Effects of Nordic Walking training on exercise capacity and fitness in men participating in early, short-term inpatient cardiac rehabilitation after an acute coronary syndrome — a controlled trial
Clinical Rehabilitation, 11/12/09
Relevance Score: 82%
Management of acute coronary syndrome in a case of Behcets disease
Blood Coagulation & Fibrinolysis, 11/03/09
Relevance Score: 82%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
Lipids in Health and Disease, 12/20/09
Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study
Age and Aging, 12/20/09
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/20/09
Today in Critical Care/Emergency...keeping you current
Receive free subspecialty "5-minute updates" via email
Study of risk factors affecting the survival rate of emergency victims with "chest pain" as chief complaint
Indian Journal of Community Medicine, 12/20/09
Gender differences in patients with acute ischemic stroke
Women's Health, 12/18/09
Emotional Regulation and Acute Pain Perception in Women
The Journal of Pain, 12/17/09
Today in General Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Doctor-patient communication with people with intellectual disability - a qualitative study
BMC Family Practice, 12/20/09
Influence of sex hormones and phytoestrogens on heart disease in men and women
Women's Health, 12/20/09
Medical waiting periods: imminence, emotions and coping
Women's Health, 12/19/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


